104 related articles for article (PubMed ID: 1366140)
21. Analysis of elevated serum interleukin-6 levels in rheumatoid arthritis: correlation with erythrocyte sedimentation rate or C-reactive protein.
Cohick CB; Furst DE; Quagliata S; Corcoran KA; Steere KJ; Yager JG; Lindsley HB
J Lab Clin Med; 1994 May; 123(5):721-7. PubMed ID: 8195678
[TBL] [Abstract][Full Text] [Related]
22. Age adjustment corrects for apparent differences in erythrocyte sedimentation rate and C-reactive protein values at the onset of seropositive rheumatoid arthritis in younger and older patients.
Ranganath VK; Elashoff DA; Khanna D; Park G; Peter JB; Paulus HE;
J Rheumatol; 2005 Jun; 32(6):1040-2. PubMed ID: 15940764
[TBL] [Abstract][Full Text] [Related]
23. [Behavior of the complement components C3 and C4, C-reactive protein and blood sedimentation rate for activity control in arthritis patients during thermo-hydrotherapy].
Günther R; Spath P; Egg D; Geier W; Nachbauer E
Z Rheumatol; 1978; 37(1-2):33-9. PubMed ID: 629093
[TBL] [Abstract][Full Text] [Related]
24. How useful are bone turnover markers in rheumatoid arthritis? Influence of disease activity and corticosteroid therapy.
Cortet B; Flipo RM; Pigny P; Duquesnoy B; Racadot A; Boersma A; Delcambre B
Rev Rhum Engl Ed; 1997 Mar; 64(3):153-9. PubMed ID: 9090763
[TBL] [Abstract][Full Text] [Related]
25. [The value of individual laboratory tests in the evaluation of inflammatory activity in rheumatoid arthritis].
Domljan Z; Sacer D
Reumatizam; 1989; 36(1-6):31-4. PubMed ID: 2491400
[TBL] [Abstract][Full Text] [Related]
26. [Results of clinical management of patients with very active rheumatoid arthritis. Comparative demonstration of therapy with non-steroid antiphlogistics, gold salts and the immunosuppressive agents proresid and endoxan].
Wawrzyńska-Pagowska J; Graff-Wróblewska T; Juszczyk T; Michalski J; Pakula A; Piotrowska D; Scislowska M
Z Rheumaforsch; 1973; 32(1):32-9. PubMed ID: 4693416
[No Abstract] [Full Text] [Related]
27. Liver toxicity profile in gold-treated Egyptian rheumatoid arthritis patients.
Koryem HK; Taha KM; Ibrahim IK; Younes LK
Int J Clin Pharmacol Res; 1998; 18(1):31-7. PubMed ID: 9604732
[TBL] [Abstract][Full Text] [Related]
28. [Diagnosis of rheumatoid arthritis activity].
Erov NK; Petrova VI; Shukurov OSh
Ter Arkh; 1977; 49(12):93-5. PubMed ID: 74862
[No Abstract] [Full Text] [Related]
29. [Use of gold salts in the treatment of rheumatoid arthritis in a group of our patients].
Vitaus M; Androić S; Car A
Reumatizam; 1977; 24(5):161-3. PubMed ID: 412242
[No Abstract] [Full Text] [Related]
30. A review of the effects of levamisole on erythrocyte sedimentation rate, acute phase proteins, and anemia.
Sany J
J Rheumatol Suppl; 1978; 4():43-7. PubMed ID: 366142
[TBL] [Abstract][Full Text] [Related]
31. Inter-relationships of laboratory variables in rheumatoid arthritis.
Haataja M; Kalliomaki JL
J Rheumatol; 1978; 5(3):263-6. PubMed ID: 748550
[TBL] [Abstract][Full Text] [Related]
32. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis.
Wolfe F
J Rheumatol; 1997 Aug; 24(8):1477-85. PubMed ID: 9263138
[TBL] [Abstract][Full Text] [Related]
33. Erythrocyte membrane gold levels after treatment with auranofin and sodium aurothiomalate.
Iqbal MS; Saeed M; Taqi SG
Biol Trace Elem Res; 2008; 126(1-3):56-64. PubMed ID: 18649049
[TBL] [Abstract][Full Text] [Related]
34. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
[TBL] [Abstract][Full Text] [Related]
35. Effects of rifampicin with and without isoniazid in rheumatoid arthritis.
McConkey B; Situnayake RD
J Rheumatol; 1988 Jan; 15(1):46-50. PubMed ID: 3351840
[TBL] [Abstract][Full Text] [Related]
36. Serum sulfhydryl levels in rheumatoid patients treated with gold thiomalate and penicillamine.
Haataja M; Nissilä M; Ruutsalo HM
Scand J Rheumatol; 1978; 7(4):212-4. PubMed ID: 104378
[TBL] [Abstract][Full Text] [Related]
37. A study of the influence of various antirheumatic drug regimens on serum acute-phase proteins, plasma tryptophan, and erythrocyte sedimentation rate in rheumatoid arthritis.
Aylward M; Maddock J; Wheeldon R; Parker RJ
Rheumatol Rehabil; 1975 May; 14(2):101-14. PubMed ID: 238274
[TBL] [Abstract][Full Text] [Related]
38. [Refined diagnosis of C-reactive protein for the detection and course control of chronic inflammatory rheumatic processes].
Peter A
Z Gesamte Inn Med; 1976 May; 31(10):330-3. PubMed ID: 822608
[TBL] [Abstract][Full Text] [Related]
39. Does second-line therapy affect the radiological progression of rheumatoid arthritis?
Pullar T; Hunter JA; Capell HA
Ann Rheum Dis; 1984 Feb; 43(1):18-23. PubMed ID: 6421253
[TBL] [Abstract][Full Text] [Related]
40. Serum concentrations of soluble interleukin 2 receptor in patients with rheumatoid arthritis: effect of second line drugs.
Crilly A; Madhok R; Watson J; Capell HA
Ann Rheum Dis; 1993 Jan; 52(1):58-60. PubMed ID: 8093995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
